- Home
- PSNY vs MNKD Comparison
PSNY vs MNKD Comparison
Compare PSNY & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSNY
- MNKD
- Stock Information
- Founded
- PSNY 2017
- MNKD 1991
- Country
- PSNY Sweden
- MNKD United States
- Employees
- PSNY N/A
- MNKD N/A
- Industry
- PSNY Auto Manufacturing
- MNKD Biotechnology: Pharmaceutical Preparations
- Sector
- PSNY Consumer Discretionary
- MNKD Health Care
- Exchange
- PSNY Nasdaq
- MNKD Nasdaq
- Market Cap
- PSNY 2.3B
- MNKD 1.9B
- IPO Year
- PSNY N/A
- MNKD 2004
- Fundamental
- Price
- PSNY $1.10
- MNKD $6.04
- Analyst Decision
- PSNY Hold
- MNKD Buy
- Analyst Count
- PSNY 8
- MNKD 6
- Target Price
- PSNY $1.39
- MNKD $8.92
- AVG Volume (30 Days)
- PSNY 5.8M
- MNKD 2.5M
- Earning Date
- PSNY 02-10-2025
- MNKD 02-25-2025
- Dividend Yield
- PSNY N/A
- MNKD N/A
- EPS Growth
- PSNY N/A
- MNKD N/A
- EPS
- PSNY N/A
- MNKD 0.08
- Revenue
- PSNY $2,046,740,000.00
- MNKD $267,200,000.00
- Revenue This Year
- PSNY $33.53
- MNKD $45.45
- Revenue Next Year
- PSNY $105.29
- MNKD $16.45
- P/E Ratio
- PSNY N/A
- MNKD $76.18
- Revenue Growth
- PSNY N/A
- MNKD 51.35
- 52 Week Low
- PSNY $0.61
- MNKD $3.17
- 52 Week High
- PSNY $2.33
- MNKD $7.63
- Technical
- Relative Strength Index (RSI)
- PSNY 49.39
- MNKD 38.99
- Support Level
- PSNY $1.03
- MNKD $5.79
- Resistance Level
- PSNY $1.24
- MNKD $6.32
- Average True Range (ATR)
- PSNY 0.10
- MNKD 0.20
- MACD
- PSNY 0.00
- MNKD -0.03
- Stochastic Oscillator
- PSNY 33.33
- MNKD 26.04
About PSNY Polestar Automotive Holding UK PLC ADS
Polestar Automotive Holding UK PLC operates as an electric vehicle manufacturer. It engages in designing products that are engineered to excite consumers and drive change. Polestar defines market-leading standards in design, technology, and sustainability. Polestar was established as a premium electric car brand by Volvo Cars and Geely Holdings. Polestar has produced two electric performance cars namely Polestar 1 and Polestar 2. Geographically, it derives a majority of revenue from USA.
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.